Programs

  • Program 1 [2020]

    THE OSTEOSARCOMA INSTITUTE ESTABLISHED AN OSTEOSARCOMA INFORMATION HOTLINE AS A FREE SERVICE TO PATIENTS, IN COLLABORATION WITH THE HONORHEALTH RESEARCH INSTITUTE OF SCOTTSDALE, AZ. CALLERS SPEAK WITH AN EXPERIENCED NURSE NAVIGATOR, WHO WORKS WITH A SARCOMA EXPERT PHYSICIAN TO PROVIDE INFORMATION AND ANSWER PATIENT QUESTIONS.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $133.5K

  • Program 2 [2020]

    THE OSTEOSARCOMA INSTITUTE COMMITTED TO FUND $200,000 FOR PHASE II MULTI-ARM CLINICAL TRIAL STUDY OF DURVALUMAB (ANTI-PD-L1) AND OLECLUMAB OSTEOSARCOMA AT THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER. $125,000 OF THIS WAS FUNDED IN 2020.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $172.3K

  • Program 3 [2020]

    THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A $500,000 PRECLINICAL AND TRANSLATIONAL SCIENCE GRANT AGREEMENT WITH CASE WESTERN RESERVE UNIVERSITY. $250,000 OF THIS WAS FUNDED IN 2020.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $344.6K